chrisvoncsefalvay/vaers-outcomes huggingface dataset:
06-28-2021; I started to feel sick.  On 06-30-2021; I went to doctor due to seasonal allergies, itchy eyes, congestion. This year the symptoms have been worsened tan the previous years. I also started to have pain in my jaw and behind my ears on both sides and the pain in my jaw got worse that I could not eat.    I am still having sneezing, drainage from my sinuses and a bit of cough from the drainage and I am getting much better with the medication I am taking
Sudden onset of severe pain in Left knee; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50-year-old female patient received BNT162b2 (BNT162B2), on 17Aug2021 at 08:00 as dose 1, single (Batch/Lot number: unknown) at the age of 50 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Acid reflux" (unspecified if ongoing). There were no concomitant medications. The following information was reported: ARTHRALGIA (non-serious) with onset 24Aug2021, outcome "not recovered", described as "Sudden onset of severe pain in Left knee". Therapeutic measures were not taken as a result of arthralgia.  Additional information: Patient did not have COVID prior vaccination and did not test for COVID post vaccination. Patient did not have any known allergy. It was also questioned if adverse event resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and did not receive any other medications within 2 weeks of vaccination.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300287298 same patient, different vaccine dose and different event.;US-PFIZER INC-202300287305 same patient, different vaccine dose and different event.;US-PFIZER INC-202300287298 same patient, different vaccine dose and different event.;
bilateral arm pain followed by chest pain which was transient.  This was followed by severe "pain in her spine" which radiated to her legs.  heart rate 80's.  Oxygen saturation 95.  blood pressure high (170'2/90's) but came down.  Over the course of 15-20 minutes symptoms abated and she left the office with minimal back discomfort in good condition.  At no time did she have hives, angioedema or other usual allergic manifestations.  No treatment other than rest and close observation occurred
SOME TERRIBLE REACTIONS FROM THE SHOT; This spontaneous report received from a consumer via a company representative concerned multiple patients. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported, expiry: unknown) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced some terrible reactions from the shot. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of some terrible reactions from the shot was not reported. This report was non-serious.
Pt here for 1 year vaccinations. Pt was due for Varicella, MMR, and Hep A. This RN in error drew up and gave Varicella, Hep A, and MMRV. This pt was accidentally double dosed with Varicella.
tired; headache; faint; vomit; This is a spontaneous report from a contactable consumer reported for herself. A 40-year-old female received the first dose of bnt162b2 (COVID-19 MRNA VACCINE BIONTECH, lot number unknown) via intramuscular on 04Feb2021 18:00 into left arm at a single dose for covid-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID 19. The patient medical history was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received other medications within 2 weeks of vaccination included sertraline hydrochloride (ZOLOFT). On 05Feb2021 5:30, the patient experienced faint and vomit and on 16: 00, more vomit, tired and headache all day. No treatment received for the events. Since the vaccination, the patient has not tested for COVID 19. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
This spontaneous report was received from a pharmacist regarding a patient of unknown age and gender. Information on the concurrent condition, medical history and pertinent drug allergies of the patient were not reported. On 17-NOV-2015 at time- 15:08, the patient was vaccinated with improperly stored RECOMBIVAX HB lot # L016427 (expiry date, dose #, route, dose units and anatomical location were not specified). Concomitant medication was not reported. No adverse events were reported. The high temperature and low temperature at which the product was stored were 4.1 and 2.9 (units unspecified) respectively. There were no Product Quality Complaint (PQC) involved. This is one of several reports received from same reporter. Additional information has been requested.
Swelling at injection site; Hot and sore at injection site; Redness at injection site; Hot and sore at injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE WARMTH (Hot and sore at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PAIN (Hot and sore at injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  No Medical History information was reported.  On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE WARMTH (Hot and sore at injection site) and VACCINATION SITE PAIN (Hot and sore at injection site). 19-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness at injection site). At the time of the report, VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE WARMTH (Hot and sore at injection site) and VACCINATION SITE PAIN (Hot and sore at injection site) had resolved and VACCINATION SITE ERYTHEMA (Redness at injection site) outcome was unknown.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  No treatment details and concomitant medications are reported..  The patient developed swelling, redness and hotness at injection site on 19-Feb-2021, which remained for 3 days. Then it automatically subsided. Then one week after that it came again, redness and soreness. and it subsided after  two or three days. and nowagain there is redness at the injection site.
Developed a reddish pink rash  that lasted about 3 days and itched really bad. Left a slight soreness for a couple days after.
Information has been received on 25-APR-2017 from a medical assistant regarding an unspecified number of patients of unknown ages and gender. The patients' concurrent conditions, medical history and concomitant medications were not reported. From 13-APR-2017 through 25-APR-2017, an unspecified number of patients were vaccinated with doses of PROQUAD lot # M043306, expiration 24-APR-2018 and lot # M042502, expiration 17-APR-2018 subcutaneous for prophylaxis which were improperly stored. Other suspect therapy included sterile diluent lot # M034763 expiration 22-APR-2019. The vaccines were stored between 6 degrees Fahrenheit and 14 degrees Fahrenheit for 4 hours and 14 minutes. There was no previous temperature excursion. The call was not made due to a data logger. The medical assistant confirmed that the sterile diluent used to reconstitute the PROQUAD was not improperly stored. No adverse effects were reported. No further information was reported. Follow up information was received from the medical assistant on 17-MAY-2017, referring to a 4 year old female patient. The patient administered the vaccine on 18-APR-2017. The medical assistant reported that they did not exactly know what caused the temperature excursion in April 2017, but they were thinking the door to the refrigerator might have been left slightly open. There had been no temperature excursions since that time. All telephone attempts to obtain follow-up information on 17-MAY-2017 had been unsuccessful. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1704USA013406: US-009507513-1705USA014055: US-009507513-1705USA014056: US-009507513-1705USA014058: US-009507513-1705USA014059: US-009507513-1705USA014060: US-009507513-1705USA014061: US-009507513-1705USA014062: US-009507513-1705USA014063: US-009507513-1705USA014064: US-009507513-1705USA014065: US-009507513-1705USA014066: US-009507513-1705USA014067: US-009507513-1705USA014068.
1. Immediate dizziness after injection. 2. Was not kept for observation in case of allergic reaction 3. Arm was shaky and injection site sore to the touch for 3 days after 4. Muscle Spasms in arm and neck for 4 days after injection 5. Swollen Lymph-node in left breast/ under arm.  6. General feeling of being unwell the day after. 7. Ringing in ears.
I received Vaccine on 03/05/2021  and the next day I noticed wheezing and could not take a deep breath.. The following day I felt like something sitting on my chest.  On 03/07/2021 I could not walk across the parking lot without giving out of breath. From 03/08/2021 up until now I have been to several Hospitals and Doctors. Diagnosed on 3/16/2021 at A Medical Center with Acute Systolic and Diastolic CHF .
This spontaneous report was received from a Certified Medical Assistant referring to unspecified number of unspecified patients. Patient's medical history and concurrent conditions were not reported. On an unknown date, the patients were vaccinated with improperly stored GARDASIL 9 lot # L016429 and expiry date 09-AUG-2-17 (strength, dose, frequency and route were not reported). Concomitant medications were not provided. No adverse effects were reported and no product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Persistent diffuse joint pain, Reynauds, skin lupus, dysphagia, cardiac issues, decreased stamina, diagnosis pending from Rheumatology.
Employee stated she was anxious on the day of her visit.  She was able to receive the Tdap without any problems.  Soon after the IM shot, she had a TB skin test placed on the R forearm and at that point, she became clammy, closed her eyes and appeared to have a seizure (witnessed by our nurse and MA), head going limp and made a snoring sound before coming to in a few seconds.  She remained a little groggy for a few  more minutes until she felt up to moving from a sitting position.  She reported being so anxious earlier in the morning that whatever she ate for breakfast, she threw up.   We provided her some oral fluids (orange juice) and she felt better.
This is a spontaneous report from a contactable other healthcare professional (physician assistant). A patient of unspecified age, ethnicity and gender started to receive PREVNAR 13, (lot number and expiration date unknown) via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the reporter stated that the patient experienced erythema indurated, very burning and very warm. The reporter also described erythema as red and indurated, very hard, burning and very painful. The reporter wanted to give hydralazine and was querying if there was anything else that can be given to the patient and hydralazine and ice pack. The outcome of the events was unknown. The following information on the batch number has been requested.
Patient received Moderna Covid-19 Bivalent instead of second dose of monovalent; No adverse event; This spontaneous case was reported by a patient family member or friend and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient received Moderna Covid-19 Bivalent instead of second dose of monovalent) and NO ADVERSE EVENT (No adverse event) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. ASKU) for COVID-19 prophylaxis.   No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Patient received Moderna Covid-19 Bivalent instead of second dose of monovalent) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient received Moderna Covid-19 Bivalent instead of second dose of monovalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient received Moderna Covid-19 Bivalent instead of second dose of monovalent).    No concomitant medications were reported.  Both my children were given Moderna Covid-19 Bivalent instead of 2nd dose of monovalent.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-716989 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-716989:same reporter
Just received 3rd MMR injection.  She should have only received 2 MMR injections.
Body aches from head to toe, chills, shortness of breath, rapid heartbeat, pain developed in upper stomach at sternum level, in my hiatal hernia region, nausea, uncontrollable bowls as if I had taken a 'bowl prep' such as for colonoscopy. 8 days after injection, still having pain in stomach, nausea, bowl movements not back to normal.
Small grape size lump on 4/30, by 5/12 the lump decreased in size to a pea size or smaller. I had a dermatologist appointment on 5/12 to have her check it out and she suggested I have my general doctor look at it. Had an appointment with my general doctor on 5/18 and she had me get blood work and ultrasound on my neck. Blood work and ultrasound done on 6/3.  No symptoms to report just the size of lump decreased within a week of noticing the lump
Approximately 48 hours after shot I started feeling very warm flush and experiencing tingling in hands and feet.  No fever, headache or joint pain.  Also just not feeling like myself. Lack of concentration,  agitated, general fatigue.  Hand and feet tingling has been worse and night and causing interrupted sleep. This feeling has not gone away and I'm now past two weeks since shot and Wondering if I should get second dose.
Pt recvd vax 23JUL92 fever of 105.2 R in ER; had ear infect & given ATB; red rash;
pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PAIN (pain). At the time of the report, PAIN (pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Non-Significant follow up
Client presented at the vaccination site on 12.26.21. Client reported he received first dose of Pfizer COVID vaccine on 04/29/21, she had only pain at the injection site lasted only one day. Client reported with her second dose of Pfizer COVID vaccine on 05/20/21, she said after five to six hours she had the chills, headache, tiredness, fever, body ache which lasted for three days. Client reported she took Tylenol for the fever and body ache with the second dose of Pfizer COVID vaccine on her second day. Client also reported with her second dose of Pfizer COVID vaccine, she lost her sense of taste and smell for three weeks. She stated she didn?t get tested during the two doses of Pizer COVID vaccine. Client stated she got COVID tested four days ago with a negative result. She reported she didn?t follow-up with her PCP after both doses. She denied shortness of breath, dizziness, or any anaphylactic symptoms with both doses. Client reported she has no chronic illnesses or any known allergy. Client is requesting for booster dose of Pfizer COVID vaccine. PHN submitted a medical consult via text message to clinical project coordinator requesting to proceed with the booster dose of Pfizer COVID vaccine. PHN received approval to proceed with the booster dose of Pfizer COVID vaccine was obtained via text message from clinical project coordinator, per CDC guidelines. Client received the booster dose of Pfizer COVID vaccine, LOT#: FL3197 on 12/26/21 at 1708 by RN. The client did not report any symptoms during the 30-minute observation period. PHN educated client on possible adverse reactions and when to seek EMS. Client verbalized understanding. Client left vaccination site at 1738 unassisted and with a steady gait.
Patient presented to another facility, so following report is from patient's monther.  Admitted with headache and fever for meningitis work up, which by all accounts was either aseptic, or negative.
Symptoms:  4cm of erythema, 1cm of induration.  Treatment:  None; recovery 4 days.
Initial misuse report received from a nurse on 14 October 2013. The four month old patient had received FLUZONE 0.25 ml dose. This would be an invalid dose per Centers for Disease Control and Prevention (CDC) and if the child requires the dose flu series then it may be initiated when the child turns six months old. (No information was provided regarding the patient). No adverse event was reported. List of documents held by sender: none.
Admitted to hospital on 04/05/023 following weakness and a fall at home. I preparation to go to Rehab, case tested positive in hospital 04/13/2023.
I63.9 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 2/2/2023 ANEMIA
Vertigo comes in waves; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo comes in waves) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced VERTIGO (Vertigo comes in waves). At the time of the report, VERTIGO (Vertigo comes in waves) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.     This case was linked to MOD-2021-106475 (Patient Link).
"Covid Arm" - itching, redness, swelling at injection site 8 days after first Moderna vaccine. Does not interfere with daily activities, just mildly annoying.
A non-serious spontaneous report of tingling in right hand, fever, runny nose, cough, aches, chills and nausea has been received from a consumer concerning an eight-year-old female, subsequent to FLUMIST. Neither relevant medical history nor concomitant medications have been reported for this patient. The patient received a dose of FLUMIST on 17-Nov-2010. On 20-Nov-2010, the patient experienced adverse symptoms of fever, runny nose, cough, aches, chills, nausea and tingling in right hand. The outcome of the events fever, runny nose, cough, aches, chills, nausea and tingling in right hand was unknown.
About 30 minutes after the shot, I did get a fine rash and began to itch, but this time was not as bad because I had taken the 50 mg of Benadryl two hours prior to taking the shot, after the shot I began tylenol,  because I was already aching and my arm hurt and was swollen and this time had a big red rash and knot., took Zofran because I was already getting nauseous.  Went home, laid down,  late afternoon, checked blood pressure, 2-21-21 110-74 heart rate 90, I was beginning to feel bad, was very tired, so went to bed woke up around 2:00 a.m. with severe headache, hurting head to toe, rash, head to toe, very nauseous, took tylenol, was unable to get Zofran, so woke my husband up he got the Zofran and also got the Blood pressure machine to check my blood pressure, it was (2 a.m.) 128-103 heart rate 75.  I was unable to go anywhere, was freezing to death, so wrapped up and finally fell back to sleep, woke up the next morning blood pressure was 2-22-21 108-78 hr 64, that night 119-72 hr 86, 2-23-21 108-78 hr 69, that night 135-85 hr 75, 2-24-21 120-73 hr 64 that night 133-80-78, 2-25-21 117-73 hr 72,/  blood pressure and heart rate have settled down, and the rash is gone, I still feel tired and arm is just a little sore, no longer having the shooting pains down my arm and out my fingers.  Have stopped tylenol and zofran, none yesterday nor today.  Feel pretty good today and the cold like symptoms are better.
Patient was seeing her PCP for a physical. Patient was given a Moderna vaccine before the age of 18. No adverse reactions were noted. Patient was assessed by nursing staff after vaccine was given. Patient tolerated vaccine well.
Soreness in arm almost immediately. 24 hours after injection I started to experience the chills, I also felt like I had a slight fever. I experienced stomach cramps, nausea and diarrhea that evening. I don't know how long those symptoms lasted because I went to bed. When I woke up in the morning the GI symptoms were gone and all that was left was some light soreness in the arm.
Fatigue, fever, body aches, chills, HA. Treatment: Ibuprofen and Tylenol Outcome: Moderate improvement of symptoms did not interfere with ADLs
PATIENT CAME TO GET A MODERNA BOOSTER (0.25ML) DOSE, BUT RECEIVED A FULL DOSE OF MODERNA ML)